SANDRA AUBREY: Open Payments
NPI 1538202817 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,592 in 139 payments from 16 companies in 2025. Trend: 2023 $1,707 · 2024 $1,623 · 2025 $1,592
Food & beverage: $1,592
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $173 |
| Lundbeck LLC | 19 | $168 |
| Corium, LLC | 20 | $168 |
| Supernus Pharmaceuticals, Inc. | 25 | $165 |
| E.R. Squibb & Sons, L.L.C. | 10 | $162 |
| Otsuka America Pharmaceutical, Inc. | 11 | $157 |
| Alkermes, Inc. | 10 | $139 |
| Vanda Pharmaceuticals Inc. | 5 | $137 |
| Janssen Pharmaceuticals, Inc | 5 | $98 |
| Noven Therapeutics, LLC | 4 | $67 |
Products named: VRAYLAR, Azstarys, Qelbree, COBENFY, ABILIFY MAINTENA, FANAPT, REXULTI, SPRAVATO.
Industry payments across KY — which companies pay providers there.
